Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,788 INR | -1.52% | -1.31% | -0.18% |
May. 31 | Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Friday Trading | MT |
May. 30 | India's pharma export sales to grow faster this year, trade body says | RE |
Sales 2024 | 280B 3.36B | Sales 2025 * | 300B 3.6B | Capitalization | 964B 11.55B |
---|---|---|---|---|---|
Net income 2024 | 55.78B 669M | Net income 2025 * | 54.89B 658M | EV / Sales 2024 | 3.43 x |
Net cash position 2024 | 64.59B 774M | Net cash position 2025 * | 88.77B 1.06B | EV / Sales 2025 * | 2.92 x |
P/E ratio 2024 |
18.4
x | P/E ratio 2025 * |
17.4
x | Employees | 25,863 |
Yield 2024 |
0.65% | Yield 2025 * |
0.78% | Free-Float | 70.84% |
Latest transcript on Dr. Reddy's Laboratories Limited
1 day | -1.52% | ||
1 week | -1.31% | ||
1 month | -6.73% | ||
3 months | -6.61% | ||
6 months | +0.70% | ||
Current year | -0.18% |
Managers | Title | Age | Since |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 18-04-01 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 20-11-01 |
Chairman | 56 | 93-01-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 86-04-07 |
Chairman | 56 | 93-01-17 | |
Kalpana Morparia
BRD | Director/Board Member | 74 | 07-06-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.02% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 5,788 | -1.52% | 11,107 |
24-05-30 | 5,877 | -2.05% | 28,799 |
24-05-29 | 6,000 | +0.74% | 4,215 |
24-05-28 | 5,956 | +1.21% | 23,164 |
24-05-27 | 5,884 | +0.34% | 8,187 |
Delayed Quote Bombay S.E., May 31, 2024 at 06:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.18% | 11.55B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- DRREDDY Stock